This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.03% per year. These returns cover a period from January 1, 1988 through July 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Eastman Chemical (EMN) Q3 Earnings Preview: How Are Events Shaping Up?
by Zacks Equity Research
Eastman Chemical (EMN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Celanese to Raise Prices of Ateva EVA & VAE Emulsion Polymers
by Zacks Equity Research
Celanese (CE) takes appropriate pricing actions amid a volatile pricing environment for raw materials.
5 Reasons to Add Eastman Chemical (EMN) to Your Portfolio
by Anindya Barman
Based on its compelling prospects, we believe Eastman Chemical (EMN) has plenty of upside potential.
Eastman Chemical Hikes DMAPA Prices Amid High Operating Costs
by Zacks Equity Research
Eastman Chemical's (EMN) latest pricing action is in response to elevated operation costs, especially of raw materials.
Eastman Chemical (EMN) is a Top Dividend Stock Right Now: Should You Buy?
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Eastman Chemical (EMN) have what it takes? Let's find out.
Celanese (CE) Poised to Gain on Productivity & Growth Actions
by Anindya Barman
Celanese's (CE) productivity actions and growth initiatives, including acquisitions, are likely to lend support to its earnings in 2018.
Eastman Chemical to be Aided by Acquisitions & Cost Reduction
by Zacks Equity Research
Eastman Chemical's (EMN) strategic acquisitions and cost-cutting actions are likely to drive growth, amid headwinds from raw-material cost inflation.
Eastman Chemical Raises Prices of Methanol Methyl Acetate
by Zacks Equity Research
Eastman Chemical (EMN) plans to lift list and off-list prices of Methyl Acetate in North America starting Oct 1.
Eastman Chemical Set to Raise Copolyesters Products Prices
by Zacks Equity Research
Eastman Chemical's (EMN) Specialty Plastic Business is implementing price increases for Copolyesters products owing to increased operating costs, especially of raw materials.
Eastman Chemical (EMN) Set to Hike Prices of Plasticizers
by Zacks Equity Research
Eastman Chemical (EMN) raises prices of plasticizers owing to increased operating costs, especially of raw materials.
Eastman Chemical (EMN) Expands PVB Production Capabilities
by Zacks Equity Research
The expansion is specifically focused on enhancing production capacity of Eastman Chemical's (EMN) advanced acoustic interlayer products.
Eastman Chemical Gets C2C Certification for Polymer Products
by Zacks Equity Research
Eastman Chemical (EMN) for the first time has been awarded the Platinum-level Material Health Certificate.
Eastman Chemical (EMN) Hikes Prices of Glycol Products
by Zacks Equity Research
Eastman Chemical (EMN) raises off-list prices of Glycol products in North and Latin America.
Eastman Chemical (EMN) Raises Prices of Plasticizers
by Zacks Equity Research
Eastman Chemical (EMN) increases Plasticizers prices due to elevated costs of raw materials.
Eastman Chemical (EMN) Raises Prices of Acids and Alcohols
by Zacks Equity Research
Eastman Chemical (EMN) hikes acid and alcohol product prices due to higher market demand and elevated operating costs of raw materials.
Eastman Chemical (EMN) Raises Off-list Prices of Benzoic Acid
by Zacks Equity Research
Eastman Chemical's (EMN) latest pricing action is in response to elevated operating expenses.
Eastman Chemical (EMN) Raises Prices of Glycol Products
by Zacks Equity Research
Eastman Chemical (EMN) raises off-list prices of products in North America.
Why Eastman Chemical (EMN) is a Top Dividend Stock
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Eastman Chemical (EMN) have what it takes? Let's find out.
Eastman Chemical (EMN) Tops Q2 Earnings, Revenue Estimates
by Anindya Barman
Eastman Chemical's (EMN) Q2 results topped expectations and the company backed its earnings growth outlook for 2018.
International Paper (IP) Q2 Earnings Beat on Higher Revenues
by Zacks Equity Research
Backed by healthy demand across its global operations, International Paper expects to deliver a second consecutive year of strong earnings growth in 2018.
Praxair (PX) Q1 Earnings & Revenues Top Estimates, Up Y/Y
by Zacks Equity Research
Praxair's (PX) 2018 performance will benefit from encouraging economic activity and strong backlog.
Will SBA Communications (SBAC) Beat Q2 Earnings on Leasing?
by Zacks Equity Research
SBA Communications' (SBAC) Q2 earnings are likely to be driven by year-over-year increase in top line.
Chemical Stock Earnings Slated on Jul 26: APD, EMN & More
by Anindya Barman
Earnings momentum for the chemical industry is expected to continue in Q2 as the fundamental driving factors remain in place.
What's in the Cards for Yamana Gold (AUY) in Q2 Earnings?
by Zacks Equity Research
Yamana Gold's (AUY) production is expected to decline in the second quarter.
Newmont (NEM) to Report Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Newmont (NEM) is likely to benefit from investment in growth projects amid higher production costs in Q2.